The new test distinguishes Zika from other viruses in mosquito vectors and launches during an ongoing outbreak that has prompted new CDC guidelines.
The researchers said that the methylation mark could potentially be used as a noninvasive biomarker for certain tumor types.
Using whole-exome sequencing early in the diagnostic process could save $3,500 on average in patients who obtain a diagnosis from it and $1,700 in patients who do not.
Digital PCR can better detect low levels of chronic myeloid leukemia in patients than other PCR-based approaches, according to Imperial College London researchers.
The company's fourth quarter revenues dropped by less than 1 percent compared to the same period last year, but missed analyst estimates.
In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.
Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.
Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.
A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.